Venture NAV Tracker / Private company
Taysha Gene Therapies, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Current disclosed marks
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| TRINTrinity Capital Inc. | senior secured loanFair Value — Secured Loan | $43MMar 31, 2026 · source ↗ | $44.2MMar 31, 2026 · source ↗ | 102.9%Mar 31, 2026 · source ↗ | Variable interest rate Prime + 4.0% or Floor rate 11.5%; EOT 5.0%Mar 31, 2026 · source ↗ | Sep 1, 2030Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.